(Q40092587)

17 September 2017

title

Lack of Fas antagonism by Met in human fatty liver disease (English)

1 reference

17 September 2017

Stephen Strom

9

0 references

author name string

Chunbin Zou

1

1 reference

17 September 2017

Jihong Ma

2

1 reference

17 September 2017

Xue Wang

3

1 reference

17 September 2017

Lida Guo

4

1 reference

17 September 2017

Zhenqi Zhu

5

1 reference

17 September 2017

John Stoops

6

1 reference

17 September 2017

Amanda E Eaker

7

1 reference

17 September 2017

Carla J Johnson

8

1 reference

17 September 2017

George K Michalopoulos

10

1 reference

17 September 2017

Marie C DeFrances

11

1 reference

17 September 2017

Reza Zarnegar

12

1 reference

17 September 2017

language of work or name

English

0 references

publication date

19 August 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

13

1 reference

17 September 2017

issue

9

1 reference

17 September 2017

page(s)

1078-1085

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1625

17 September 2017

exact match

0 references

cites work

Apoptosis: the nexus of liver injury and fibrosis.

1 reference

7 January 2021

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

1 reference

7 January 2021

Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice

1 reference

7 January 2021

Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury

1 reference

7 January 2021

Cytokines and the pathogenesis of non-alcoholic steatohepatitis

1 reference

7 January 2021

A mechanism of cell survival: sequestration of Fas by the HGF receptor Met.

1 reference

7 January 2021

Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair

1 reference

7 January 2021

Met, metastasis, motility and more

1 reference

7 January 2021

Scatter-factor and semaphorin receptors: cell signalling for invasive growth

1 reference

7 January 2021

A human hepatocellular in vitro model to investigate steatosis.

1 reference

7 January 2021

Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis

1 reference

7 January 2021

Increase in the concentration of carbon 18 monounsaturated fatty acids in the liver with hepatitis C: analysis in transgenic mice and humans

1 reference

7 January 2021

The TNF and TNF receptor superfamilies: integrating mammalian biology

1 reference

7 January 2021

The molecular architecture of the TNF superfamily

1 reference

7 January 2021

Identification of amino acid residues important for ligand binding to Fas

1 reference

7 January 2021

Fas-disabling small exocyclic peptide mimetics limit apoptosis by an unexpected mechanism.

1 reference

7 January 2021

Death Receptor Activation-Induced Hepatocyte Apoptosis and Liver Injury

1 reference

7 January 2021

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

1 reference

7 January 2021

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

1 reference

7 January 2021

Mouse models in non-alcoholic fatty liver disease and steatohepatitis research.

1 reference

7 January 2021

Rodent nutritional model of non‐alcoholic steatohepatitis: Species, strain and sex difference studies

1 reference

7 January 2021

A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections

1 reference

7 January 2021

Steatohepatitis and apoptosis: therapeutic implications

1 reference

7 January 2021

Cheating death in the liver

1 reference

7 January 2021

RNA interference targeting Fas protects mice from fulminant hepatitis

1 reference

7 January 2021

Caspase 8 small interfering RNA prevents acute liver failure in mice

1 reference

7 January 2021

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

1 reference

7 January 2021

Critical contribution of liver natural killer T cells to a murine model of hepatitis

1 reference

7 January 2021

1 reference

7 January 2021

Liver regeneration: from myth to mechanism

1 reference

7 January 2021

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

1 reference

7 January 2021

Cancer therapy: can the challenge be MET?

1 reference

7 January 2021

Prevention of hepatocellular carcinoma development associated with chronic hepatitis by anti-fas ligand antibody therapy

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1625

1 reference

release_k5pkzymaqra7vetpr7ezxrkgce

17 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k5pkzymaqra7vetpr7ezxrkgce

24 November 2022

mapped directly with Wikidata item

1 reference